Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.760
-0.140 (-7.37%)
Apr 27, 2026, 4:00 PM EDT - Market closed
Pyxis Oncology Revenue
In the year 2025, Pyxis Oncology had annual revenue of $13.86M, down -14.17%. Pyxis Oncology had revenue of $11.04M in the quarter ending December 31, 2025.
Revenue (ttm)
$13.86M
Revenue Growth
-14.17%
P/S Ratio
7.98
Revenue / Employee
$247,464
Employees
56
Market Cap
110.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.86M | -2.29M | -14.17% |
| Dec 31, 2024 | 16.15M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verrica Pharmaceuticals | 35.58M |
| Innate Pharma | 10.57M |
| Cibus | 3.64M |
| Cardiff Oncology | 593.00K |
| NeOnc Technologies Holdings | 39.99K |
PYXS News
- 10 days ago - Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 - GlobeNewsWire
- 5 weeks ago - Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity - GlobeNewsWire
- 4 months ago - Analysts Sound Alarm On Pyxis Oncology's Tiny Trial - Benzinga
- 4 months ago - Pyxis Oncology Transcript: Study Update - Transcripts
- 4 months ago - Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - GlobeNewsWire
- 5 months ago - Pyxis Oncology Transcript: Stifel 2025 Healthcare Conference - Transcripts
- 6 months ago - Pyxis Oncology Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Transcripts